Action Vivosim Labs (VIVS)
Société cotée en bourse. Voici le cours, un aperçu de l'activité et l'essentiel à savoir sur Vivosim Labs en septembre 2026.
VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company, which is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company also advances product candidates to treat inflammatory bowel disease (IBD) discovered and developed using its complex human tissue intestinal models.
Performance de croissance sur six mois
Aperçu de la performance de l'action
Santé financière
Organovo is generating low revenue, but has a strong cash flow and gross margin.
Voyez plus d'actions en téléchargeant l'application GRATUITEMENT
Cela ne prend que 60 secondes.
Pourquoi investir avec Nemo ?
Zéro commission
Négociez actions, ETF et plus encore sans commission. Gardez une plus grande part de vos gains.
Fiable et réglementé
Membre du groupe Exinity depuis 2015, au service de plus d'un million de clients dans le monde.